新闻
SIEN
--
0.00%
--
BRIEF-Sientra Inc - On July 16, Board Approved An Increase In Size Of Board From 7 Directors To 9 Directors
reuters.com · 2天前
BRIEF-Sientra Announces Appointment Of Chief Financial Officer
reuters.com · 07/12 12:18
Sientra任命安迪施密特为首席财务官
MT Newswires · 07/12 08:47
周五触及 52 周高点的股票
    Before 10 a.m. ET on Friday, 115 companies hit new 52-week highs.
Benzinga · 07/09 16:36
Sientra:资本使用洞察的回报
Sientra (NASDAQ:SIEN) reported Q1 sales of $23.24 million. Earnings fell to a loss of $9.82 million, resulting in a 42.34% decrease from last quarter. In Q4, Sientra brought in $22.64 million in sales but lost $17.03 million in earnings.
Benzinga · 06/18 14:17
资本使用回报率概览:Sientra
Sientra (NASDAQ:SIEN) reported Q1 sales of $23.24 million. Earnings fell to a loss of $9.82 million, resulting in a 42.34% decrease from last quarter. In Q4, Sientra brought in $22.64 million in sales but lost $17.03 million in earnings.
Benzinga · 06/02 13:55
MedTech综述:Lucira Health,Second Sight Medical ClearPoint Neuro,Medtronic,Sientra的更新
Lucira Health Inc (NASDAQ: LHDX) has announced that its Lucira Check IT COVID-19 test kit is now available on Amazon.com in the US. Each Lucira Check IT test kit provides a PCR quality test result at home in 30 minutes or less. The product costs $55. Price...
Benzinga · 05/12 17:47
Canaccord Genuity维持对Sientra的买入评级,将目标价格上调至10美元
Canaccord Genuity maintains Sientra (NASDAQ:SIEN) with a Buy and raises the price target from $9 to $10.
Benzinga · 05/12 15:22
Sientra(SIEN)连续第三次购买
After Canaccord Genuity and Colliers Securities gave Sientra (NASDAQ: SIEN) a Buy rating last month, the company received another Buy, this time from
SmarterAnalyst · 05/12 12:26
SVB Leerink维持Sientra跑赢大盘,将目标股价上调至11美元
SVB Leerink analyst Richard Newitter maintains Sientra (NASDAQ:SIEN) with a Outperform and raises the price target from $10 to $11.
Benzinga · 05/12 11:22
Canaccord Genuity维持Sientra(SIEN)的买入评级
In a report released yesterday, Kyle Rose from Canaccord Genuity maintained a Buy rating on Sientra (SIEN), with a price target of $10.00. The company's
SmarterAnalyst · 05/12 10:16
周三盘前交易中的26只股票
Gainers Biomerica, Inc. (NASDAQ: BMRA) shares rose 30.8% to $4.46 in pre-market trading. Biomerica recently said its COVID-19 antigen rapid test can be performed with a nasal swab.
Benzinga · 05/12 10:10
SVB Leerink将Sientra PT从10美元上调至11美元,维持优于大盘评级
MT Newswires · 05/12 09:57
全球乳房植入物市场:理解该行业竞争前景的战略分析2025 |世界上最大的乳房植入物市场肯尼斯研究说
May 12, 2021 (AmericaNewsHour) -- Kenneth Research has recently added a report titled Global Breast Implant Market in its storehouse of market research...
AmericaNewsHour · 05/12 08:01
市场增长报告称2021年乳房美学市场行业发展增长,份额,前景,规模,趋势,制造商分析和2027年区域预测
May 12, 2021 (The Expresswire) -- Global “Breast Aesthetics Market” 2021 Report provide the detailed knowledge on the forthcoming advances and product...
The Express Wire · 05/12 06:12
8-K:Sientra,Inc.
(EDGAR Online via COMTEX) -- false 0001551693 0001551693 2021-05-11 2021-05-11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 05/12 00:44
周二盘后交易中的10只股票
Gainers FuboTV (NYSE: FUBO) shares are trading higher after the company reported better-than-expected Q1 sales results and issued Q2 and FY21 sales guidance above estimates.
Benzinga · 05/11 21:32
BRIEF-Sientra - Miradry Acquisition Agreed To Buy Some Assets, Rights, & Assume Some Liabilities, Comprising Co's Miradry Business For $10 Million In Cash
reuters.com · 05/11 21:15
Brief-Sientra宣布将Miradry业务出售给1315 Capital
reuters.com · 05/11 20:41
回顾:Sientra Q1收益
Shares of Sientra (NASDAQ:SIEN) rose 10.7% in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 82.46% over the past year to ($0.10), which beat the estimate of ($0.27).
Benzinga · 05/11 20:39
微牛提供丰富的实时SIEN股票新闻,让你可以通过多个平台了解SIEN股票行情最新动态,这些免费的Sientra新闻可以帮助你做出明智投资。
SIEN 简况
Sientra Inc是一家医学美容公司。该公司的主要产品是用于隆胸和乳房重建手术的硅胶乳房植入物,它提供超过400种形状、大小和质地的产品。该公司向整形外科医生销售其乳房植入物和乳房组织扩张器或乳房产品。其乳房植入体主要用于选择性手术,这些手术通常以现金支付的方式进行。种植体纹理在种植体外壳上提供纹理,旨在减少位置不正、旋转和包膜挛缩的发生率。该公司还主要为医院和手术中心提供乳房组织扩张器,并为整形外科医生、皮肤科医生和其他专业人士提供BIOCORNEUM疤痕管理产品。该公司的品牌还包括OPUS、Luxe、Curve、AlloX2、Dermaspan和Softspan。